Table 1.
Association of anti-GP2 IgA and/or IgG with location of disease in CD.
| P = 0.002 | Anti-GP2 IgA/IgG | ||
|---|---|---|---|
| Positive | Negative | Total | |
| Ileocolonic location | |||
| Positive | 11 | 5 | 16 |
| Negative | 4 | 19 | 23 |
|
| |||
| Total | 15 | 24 | 39 |
Investigating the association of anti-GP2 IgA/IgG with different clinical phenotypes in CD, 11/16 of CD patients with ileocolonic location demonstrated anti-GP2 antibody positivity (P = 0.002).